Jacob Chacko
CIK: 0001608936
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 17, 2026FDMT
4D Molecular Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
50K shares- - Jan 2, 2026ORIC
Oric Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
675K shares- - Jan 2, 2026ORIC
Oric Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Unit
112.5K shares- - Dec 16, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct33.4K shares at avg. $9.06$302K - Dec 15, 2025ORIC
Oric Pharmaceuticals, Inc.
Exercise(M)Direct83.7K shares- - Oct 6, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct37.5K shares at avg. $12.32$462K - Oct 1, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct53K shares at avg. $12.05$639K - Sep 30, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct34.5K shares at avg. $12.01$415K - Sep 22, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct125K shares at avg. $10.80$1.3M - Jun 17, 2025FDMT
4D Molecular Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
22.5K shares- - Jan 2, 2025ORIC
Oric Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Unit
100K shares- - Jan 2, 2025ORIC
Oric Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
600K shares- - Dec 16, 2024ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct24.7K shares at avg. $8.28$204K - Dec 15, 2024ORIC
Oric Pharmaceuticals, Inc.
Exercise(M)Direct67K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  FDMT 4D Molecular Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Jan 2, 2026 |  ORIC Oric Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 675,000 | - | - | Direct |
| Jan 2, 2026 | ORIC Oric Pharmaceuticals, Inc. | Award(A) Restricted Stock Unit | 112,500 | - | - | Direct |
| Dec 16, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 33,374 | $9.06 | $302,368 | Direct |
| Dec 15, 2025 | ORIC Oric Pharmaceuticals, Inc. | Exercise(M) | 83,666 | - | - | Direct |
| Oct 6, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 37,461 | $12.32 | $461,520 | Direct |
| Oct 1, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 53,001 | $12.05 | $638,805 | Direct |
| Sep 30, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 34,538 | $12.01 | $414,750 | Direct |
| Sep 22, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 125,000 | $10.80 | $1,349,938 | Direct |
| Jun 17, 2025 | FDMT 4D Molecular Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 22,500 | - | - | Direct |
| Jan 2, 2025 | ORIC Oric Pharmaceuticals, Inc. | Award(A) Restricted Stock Unit | 100,000 | - | - | Direct |
| Jan 2, 2025 | ORIC Oric Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 600,000 | - | - | Direct |
| Dec 16, 2024 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 24,660 | $8.28 | $204,214 | Direct |
| Dec 15, 2024 | ORIC Oric Pharmaceuticals, Inc. | Exercise(M) | 67,000 | - | $0 | Direct |
1-14 of 14 transactions
About Chacko Jacob
Chacko Jacob (SEC CIK 0001608936) files insider reports with the SEC as Director of 4D Molecular Therapeutics, Inc. (FDMT) and PRESIDENT AND CEO of Oric Pharmaceuticals, Inc. (ORIC).
Signal8 holds 9 ownership filings by Chacko Jacob, all Form 4s, filed between Dec 17, 2024 and Jun 18, 2026. Those filings report 14 transactions, from Dec 15, 2024 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Chacko Jacob's filings is in EMERYVILLE, CA.
Recent filings by Chacko Jacob
- Jun 17, 2026: Grant or award of FDMT derivative securities (Form 4, code A).
- Jan 2, 2026: Grants or awards of ORIC derivative securities (2 lines, Form 4, code A).
- Dec 16, 2025: Open-market sale of ORIC shares (Form 4, code S).
- Dec 15, 2025: Option exercise of ORIC shares (Form 4, code M).
- Oct 6, 2025: Open-market sale of ORIC shares (Form 4, code S).
Other insiders filing for 4D Molecular Therapeutics, Inc. (FDMT)
- Bizily Scott, Chief Legal Officer
- Kirn David
- Tomasello Shawn, Director
- THEUER CHARLES, Director
- Miller-Rich Nancy, Director
- GRAY SUSANNAH, Director